United States securities and exchange commission logo





                            July 2, 2021

       Jeffrey M. Canouse
       Chief Executive Officer
       New America Energy Corp.
       240 Vaughan Drive Suite B
       Alpharetta, GA 30009

                                                        Re: New America Energy
Corp.
                                                            Amendment No. 3 to
Offering Statement on Form 1-A
                                                            Filed June 25, 2021
                                                            File No. 024-11444

       Dear Mr. Canouse:

             We have reviewed your amended offering statement and have the
following
       comments. In some of our comments, we may ask you to provide us with
information so we
       may better understand your disclosure.

              Please respond to this letter by amending your offering statement
and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your offering statement and the
information you
       provide in response to these comments, we may have additional comments.

       Offering Statement on Form 1-A

       General

   1.                                                   We refer to your Form
8-K filed on June 25, 2021. Please revise and update the offering
                                                        statement to reflect
this significant change to your business.
 Jeffrey M. Canouse
FirstName   LastNameJeffrey
New America    Energy Corp. M. Canouse
Comapany
July 2, 2021NameNew America Energy Corp.
July 2,2 2021 Page 2
Page
FirstName LastName
       You may contact Ibolya Ignat at (202) 551-3636 or Kate Tillan at (202)
551-3604 if you
have questions regarding comments on the financial statements and related
matters. Please
contact Dillon Hagius at (202) 551-7976 or Joe McCann at (202) 551-6262 with
any other
questions.



                                                          Sincerely,

                                                          Division of
Corporation Finance
                                                          Office of Life
Sciences
cc:      Matt Stout